The graph displays the number of a pharmaceutical company’s sales, by country, between 2002 and 2006.
Overall, Asia saw a steady rise, where it managed to surpass America and Europe during the five-year period. On the other hand, America and Europe experienced a decrease in sales from 2002 to 2006.
Asia initially held the lowest value between the three nations, only making up a quarter of the sales in 2002. Despite this, Asia revealed an annual increase of 5%, with the exception of 2005 where it only grew by 2% before continuing this trend in the final year. During the last year, Asia covered 40% in sales becoming the highest of all three countries.
America originally covered 41% of sales in 2002, which was the culminating point throughout the years. America revealed a consistent decrease for 3 years, finally bouncing back to 29% and 30% in 2005 and 2006, respectively. In contrast, Europe hovered around 30-40%, peaking at 38% during 2004. In the end, Europe and America both made up 30% of sales despite the 7% gap in the beginning.
